Option Investor
Newsletter

Additional put write for OCTOBER RECOMMENDED LIST

HAVING TROUBLE PRINTING?
Printer friendly version


ADDITIONAL PUT WRITE TO THE OCTOBER RECOMMENDED LIST

We are looking to add The following put write to our RECOMMENDED
LIST FOR OCTOBER

HGSI - Human Genome Sciences, Inc.
operates as a biopharmaceutical company with a pipeline of novel protein and antibody drugs. Thecompany's drugs in clinical development include LymphoStat-BTM for
the treatment of lupus and rheumatoid arthritis; AlbuferonTM for the treatment of
chronic hepatitis C; HGS-ETR1, HGS-ETR2, HGS-TR2J for the treatment of solid
and hematopoietic cancers; CCR5 mAb for the treatment of HIV/ AIDS; and
ABthraxTM for the treatment of anthrax infection.

We are reommending the following put write


SELL HGSI OCT $10.00 PUT HQI-VB
Target Price $30.00 or $0.30
Potential Profit( 10 x = $300.00
Initial Margin $3,018 10 (contracts)
Return on Investment 9.94%
Cost Basis in Stock = $9.70
Days to Expiration = 19


Option Writers Newsletter Archives